Glucagon-like peptide-1 receptor

Results 231 to 240 of about 60,658 (250)

Some of the next articles are maybe not open access.

The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists

Current Medicinal Chemistry
Abstract: Diabetes mellitus has become a serious life-threatening disease. As one of the new drugs for the treatment of diabetes, GLP-1 receptor agonists have attracted a lot of attention. Compared with traditional hypoglycemic drugs, GLP-1 receptor agonists have good safety and tolerability. To a certain extent, they overcome the problem of the short
Haowen, Fang, Bing, Niu, Qin, Chen
openaire +2 more sources

Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

Circulation, 2022
, Bernard Zinman, Ahmed Shaman
exaly

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease

International Journal of COPD, 2023
Hang Qian, Handong Yang, Jun Chen
exaly

Association of glucagon‐like peptide‐1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy

Journal of Diabetes Investigation, 2023
Tetsuya Kubota, Yukiko Onishi
exaly

Glucagon-Like Peptide-1 Receptor Agonists and Cancer